Kimberly-Clark IPC — Research, Selling and General Expense decreased by 10.2% to $168.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.0%, from $175.00M to $168.00M. Over 3 years (FY 2022 to FY 2025), IPC — Research, Selling and General Expense shows relatively stable performance with a -2.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A decrease relative to revenue suggests improved operational leverage and administrative efficiency.
Operating expenses incurred by a segment that are not directly tied to production, including research and development, s...
Often grouped within SG&A expenses in segment reporting for diversified firms.
kmb_segment_ipc_research_selling_and_general_expense| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $191.00M | $191.00M | $191.00M | $191.00M | $190.75M | $190.75M | $190.75M | $190.75M | $175.00M | $185.00M | $182.00M | $196.00M | $175.00M | $183.00M | $173.00M | $187.00M | $168.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -0.1% | +0.0% | +0.0% | +0.0% | -8.3% | +5.7% | -1.6% | +7.7% | -10.7% | +4.6% | -5.5% | +8.1% | -10.2% |
| YoY Change | — | — | — | — | -0.1% | -0.1% | -0.1% | -0.1% | -8.3% | -3.0% | -4.6% | +2.8% | +0.0% | -1.1% | -4.9% | -4.6% | -4.0% |